Voss Capital LLC Raises Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)

Voss Capital LLC raised its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 207.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,835,000 shares of the company's stock after acquiring an additional 1,238,580 shares during the period. Cellebrite DI makes up 1.5% of Voss Capital LLC's portfolio, making the stock its 18th biggest position. Voss Capital LLC owned about 0.97% of Cellebrite DI worth $15,891,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CLBT. UBS Group AG purchased a new position in shares of Cellebrite DI in the 1st quarter valued at $26,000. Lazard Asset Management LLC acquired a new stake in Cellebrite DI in the 4th quarter valued at $32,000. Steward Partners Investment Advisory LLC raised its position in Cellebrite DI by 81.4% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 7,784 shares of the company's stock valued at $34,000 after purchasing an additional 3,494 shares during the period. New York State Common Retirement Fund acquired a new position in shares of Cellebrite DI during the first quarter worth about $35,000. Finally, State of Tennessee Treasury Department purchased a new stake in shares of Cellebrite DI in the first quarter worth about $48,000. 45.88% of the stock is currently owned by institutional investors and hedge funds.

Cellebrite DI Stock Performance

Shares of CLBT stock traded down $0.17 during mid-day trading on Monday, hitting $10.38. 694,694 shares of the stock traded hands, compared to its average volume of 974,703. Cellebrite DI Ltd. has a twelve month low of $5.22 and a twelve month high of $12.50. The company's 50-day simple moving average is $11.12 and its 200-day simple moving average is $9.11. The firm has a market cap of $2.13 billion, a price-to-earnings ratio of -24.53, a price-to-earnings-growth ratio of 1.86 and a beta of 1.54.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last released its earnings results on Thursday, February 15th. The company reported $0.08 EPS for the quarter, topping analysts' consensus estimates of $0.06 by $0.02. The business had revenue of $93.01 million for the quarter, compared to the consensus estimate of $85.43 million. Cellebrite DI had a negative net margin of 24.94% and a positive return on equity of 173.14%. Analysts forecast that Cellebrite DI Ltd. will post 0.32 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Needham & Company LLC boosted their price objective on shares of Cellebrite DI from $13.00 to $13.50 and gave the stock a "buy" rating in a report on Thursday, March 28th. Craig Hallum increased their price target on Cellebrite DI from $14.00 to $16.00 and gave the company a "buy" rating in a report on Monday, April 1st. William Blair upgraded Cellebrite DI from a "market perform" rating to an "outperform" rating in a report on Wednesday, March 13th. Finally, Bank of America upped their target price on Cellebrite DI from $12.00 to $13.00 and gave the company a "buy" rating in a research report on Monday, April 1st. Five analysts have rated the stock with a buy rating, According to MarketBeat, the stock has an average rating of "Buy" and an average price target of $12.30.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.